ICOS and hepatocellular carcinoma: An increased expression of ICOS-L by pDCs has been reported in hepatocellular carcinoma (HCC) [180] and ovarian carcinoma [181], in which the presence of TA-pDCs and ICOS+ Tregs was predictive for disease progression [182].